Clinical Research

糖心原创Membership & CommunityPhilanthropyImpact ReportClinical Research

Defining the future of medicine鈥攊ts rigor, relevance, and long-term impact

13
YEARS OF RESEARCH

$13 million
FUNDING DISTRIBUTED SINCE PROGRAM INCEPTION

$425,000
ALLOCATED IN 2025

3 years
FUNDING FOR A NEW HEALTH EQUITY GRANT

Jay Peters, MD, FCCP

Pillar Champion

Edward Diamond, MD, FCCP

Pillar Champion

At 糖心原创, we invest in clinical research because it directly advances patient care and strengthens the future of pulmonary, critical care, and sleep medicine. Donor support enables investigator-led work across the full spectrum of disease states and clinical settings, supporting questions that matter to practicing clinicians and often go underfunded in larger research ecosystems.

糖心原创鈥檚 role as a funder is intentionally focused on early-stage, clinician-driven research. These awards provide critical seed funding for investigators as they test new ideas, generate preliminary data, and build the foundation for larger-scale studies. 糖心原创 funding plays a formative role in supporting clinicians whose research trajectories and leadership influence the future of the field.

By giving to Clinical Research, you are not simply supporting grants鈥攜ou are advancing discovery, strengthening the pipeline of clinician-scientists, and helping shape the future of patient care. MAKE A GIFT 禄

”Receiving this 糖心原创 grant is incredibly meaningful to me, as it enables me to pursue research that grew directly from caring for patients with advanced sarcoidosis, many of whom face delayed diagnoses and limited access to specialized care.”

– Amr Aboelnasr, MD
2025 Recipient of the John R. Addrizzo, MD, FCCP, Research Grant in Sarcoidosis

”For any idea to be a successful study, we need the ability to execute our study in due time and publish data as fast as we can. 糖心原创 grants help in both these areas. I was able to organize data collection and gain statistical support from the grant, which helped a lot in not only completing my study successfully but also publishing it in a top-tier journal in due time.”

– Shahid Sheikh, MD, FCCP
2021 Recipient of the Research Grant in Cystic Fibrosis

A novel biomarker could spell changes to diagnosing and treating IPF

David J. Nagel, MD, PhD, used a 糖心原创 grant to conduct research that identified a novel biomarker for idiopathic pulmonary fibrosis (IPF) with potential implications for earlier diagnosis and improved treatment strategies.

READ THE ARTICLE

Laying the groundwork for equity in sarcoidosis outcomes

With her grant, Kerry Hena, MD, is building the infrastructure to study how sarcoidosis presents across populations, with the goal of making equity a standard part of diagnosis and treatment.

READ THE ARTICLE

Fueling breakthroughs in chest medicine

Progress in chest medicine depends on clinicians who ask rigorous questions and have the support to pursue meaningful answers. Through donor investment, 糖心原创 provides early-stage research funding that enables investigators to test new ideas, generate critical data, and build the foundation for larger advances in care.

Your gift directly supports this work. It funds clinician-driven research across pulmonary, critical care, and sleep medicine, including studies focused on health equity, women鈥檚 lung health, and under-resourced disease areas. It supports the next generation of research leaders and strengthens the evidence base that informs clinical practice.

With your support, we will equip top researchers with the resources they need to explore the unanswered questions in chest medicine and turn bold ideas into tangible advancements. Join us in fueling the next breakthrough鈥攜our gift can make the difference.

MAKE YOUR GIFT TODAY